Effects of Obesity on Warfarin Reversal With Vitamin K.

Authors

Stanley A Luc
Maegan M Whitworth
Shawna E King, Providence Alaska Medical Center, Anchorage, AK, USAFollow

Document Type

Article

Publication Date

1-1-2019

Publication Title

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Keywords

anticoagulants; bleeding; clinical pharmacology

Abstract

Phytonadione (vitamin K1, VK) is fat soluble and may be sequestered by adipose tissue, thus potentially altering drug distribution in obese patients requiring warfarin reversal. This single-center retrospective cohort study aimed to determine the effects of obesity (defined as body mass index [BMI] ≥ 30 kg/m

Department

Pharmacy

Department

Nutrition

Recommended Citation

Luc, Stanley A; Whitworth, Maegan M; and King, Shawna E, "Effects of Obesity on Warfarin Reversal With Vitamin K." (2019). Articles, Abstracts, and Reports. 1125.
https://digitalcommons.providence.org/publications/1125